Valneva SE

Valneva SEverified

VALN

Price:

$8.84

Market Cap:

$651.59M

Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing Enterotoxigenic Escherichia coli bacterium; and VLA2001, a vaccine candidate against SARS-CoV-2. The company also develops VLA15, a vaccine candidate that has completed Phase II clinical trial against Borrelia; and VLA1553, a vaccine can...[Read more]

Industry

Biotechnology

IPO Date

2021-05-05

Stock Exchange

NASDAQ

Ticker

VALN

The Enterprise Value as of December 2025 (TTM) for Valneva SE (VALN) is 687.21M

According to Valneva SE’s latest financial reports and current stock price. The company's current Enterprise Value is 687.21M. This represents a change of 57.57% compared to the average of 436.13M of the last 4 quarters.

Valneva SE (VALN) Historical Enterprise Value (quarterly & annually)

How has VALN Enterprise Value performed in the past?

The mean historical Enterprise Value of Valneva SE over the last ten years is 581.68M. The current 687.21M Enterprise Value has changed 11.71% with respect to the historical average. Over the past ten years (40 quarters), VALN's Enterprise Value was at its highest in in the December 2021 quarter at 2.24B. The Enterprise Value was at its lowest in in the September 2021 quarter at 0.

Quarterly (TTM)
Annual

Average

581.68M

Median

352.67M

Minimum

235.79M

Maximum

2.16B

Valneva SE (VALN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Valneva SE Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 257.31%

Maximum Annual Enterprise Value = 2.16B

Minimum Annual Increase = -73.07%

Minimum Annual Enterprise Value = 235.79M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024362.77M-50.88%
2023738.55M26.97%
2022581.66M-73.07%
20212.16B257.31%
2020604.43M135.59%
2019256.56M8.81%
2018235.79M-8.21%
2017256.87M-7.58%
2016277.93M-18.87%
2015342.58M22.53%

Valneva SE (VALN) Average Enterprise Value

How has VALN Enterprise Value performed in the past?

The current Enterprise Value of Valneva SE (VALN) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

560.99M

5-year avg

889.42M

10-year avg

581.68M

Valneva SE (VALN) Enterprise Value vs. Peers

How is VALN’s Enterprise Value compared to its peers?

Valneva SE’s Enterprise Value is less than Day One Biopharmaceuticals, Inc. (815.93M), less than Arvinas, Inc. (819.49M), less than ArriVent BioPharma, Inc. Common Stock (892.49M), greater than Astria Therapeutics, Inc. (677.40M), less than Geron Corporation (854.51M), less than Replimune Group, Inc. (804.93M), greater than MeiraGTx Holdings plc (679.86M), less than MBX Biosciences, Inc. Common Stock (803.43M), less than Ginkgo Bioworks Holdings, Inc. (815.10M), greater than Iovance Biotherapeutics, Inc. (650.41M),

Build a custom stock screener for Valneva SE (VALN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Valneva SE using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Valneva SE (VALN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Valneva SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Valneva SE's Enterprise Value?

What is the highest Enterprise Value for Valneva SE (VALN)?

What is the 3-year average Enterprise Value for Valneva SE (VALN)?

What is the 5-year average Enterprise Value for Valneva SE (VALN)?

How does the current Enterprise Value for Valneva SE (VALN) compare to its historical average?